Cargando…

Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents

Prodrug design for brain delivery of small- and medium-sized neuropeptides was reviewed, focusing on thyrotropin-releasing hormone and structurally related peptides as examples. We have summarized our most important advances in methodology, as well as assessed the benefits and limitations of bioreve...

Descripción completa

Detalles Bibliográficos
Autores principales: Prokai-Tatrai, Katalin, Prokai, Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253886/
https://www.ncbi.nlm.nih.gov/pubmed/19214153
http://dx.doi.org/10.3390/molecules14020633
_version_ 1783373597039919104
author Prokai-Tatrai, Katalin
Prokai, Laszlo
author_facet Prokai-Tatrai, Katalin
Prokai, Laszlo
author_sort Prokai-Tatrai, Katalin
collection PubMed
description Prodrug design for brain delivery of small- and medium-sized neuropeptides was reviewed, focusing on thyrotropin-releasing hormone and structurally related peptides as examples. We have summarized our most important advances in methodology, as well as assessed the benefits and limitations of bioreversible chemical manipulation techniques to achieve targeting of the parent molecules into the central nervous system. The value of prodrug-amenable analogues as potential drug-like central nervous systems agents was highlighted.
format Online
Article
Text
id pubmed-6253886
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-62538862018-11-30 Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents Prokai-Tatrai, Katalin Prokai, Laszlo Molecules Review Prodrug design for brain delivery of small- and medium-sized neuropeptides was reviewed, focusing on thyrotropin-releasing hormone and structurally related peptides as examples. We have summarized our most important advances in methodology, as well as assessed the benefits and limitations of bioreversible chemical manipulation techniques to achieve targeting of the parent molecules into the central nervous system. The value of prodrug-amenable analogues as potential drug-like central nervous systems agents was highlighted. Molecular Diversity Preservation International 2009-02-06 /pmc/articles/PMC6253886/ /pubmed/19214153 http://dx.doi.org/10.3390/molecules14020633 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Prokai-Tatrai, Katalin
Prokai, Laszlo
Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
title Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
title_full Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
title_fullStr Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
title_full_unstemmed Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
title_short Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
title_sort prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253886/
https://www.ncbi.nlm.nih.gov/pubmed/19214153
http://dx.doi.org/10.3390/molecules14020633
work_keys_str_mv AT prokaitatraikatalin prodrugsofthyrotropinreleasinghormoneandrelatedpeptidesascentralnervoussystemagents
AT prokailaszlo prodrugsofthyrotropinreleasinghormoneandrelatedpeptidesascentralnervoussystemagents